Labat AfricaJSE:LAB +66.67% PB Ratio is 0.33 as of Jun. 25, 2026, which is 92% below its 10-year median of 4.17. The stock has 5 warning signs investors should review. Among 922 Drug Manufacturers companies, Labat Africa ranks better than 95.88% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-25), Labat Africa's share price is R0.05. Labat Africa's Book Value per Share for the quarter that ended in Nov. 2025 was R0.15. Hence, Labat Africa's PB Ratio of today is 0.33.
Good Sign:
Labat Africa Ltd stock PB Ratio (=0.33) is close to 10-year low of 0.33.
The historical rank and industry rank for Labat Africa's PB Ratio or its related term are showing as below:
JSE:LAB'
s PB Ratio Range Over the Past 10 Years
Min: 0.33 Med: 4.17 Max: 145
Current: 0.33
During the past 13 years, Labat Africa's highest PB Ratio was 145.00. The lowest was 0.33. And the median was 4.17.
JSE:LAB's PB Ratio is ranked better than 95.88% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.855
vs JSE:LAB: 0.33
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Labat Africa was 263.40% per year. The lowest was -54.90% per year. And the median was 25.80% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Labat Africa PB Ratio Related Terms
Labat Africa PB Ratio Historical Data
* Premium members only.
The historical data trend for Labat Africa's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Labat Africa's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labat Africa PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Labat Africa's PB Ratio distribution charts can be found below:
* The bar in red indicates where Labat Africa's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Labat Africa's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Labat Africa (JSE:LAB) has a PB Ratio of 0.33 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Labat Africa and its competitors. This is 92% below median its historical median of 4.17. Over the past decade, Labat Africa's PB Ratio has ranged from 0.33 to 145.00. According to the industry distribution chart, Labat Africa ranks #38 out of 922 companies in the Drug Manufacturers industry, placing it in the top 4.1%.
Is Labat Africa's PB Ratio too high?
Labat Africa's current PB Ratio of 0.33 is 92% below median its 10-year median of 4.17. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 145.00. The Drug Manufacturers industry median PB Ratio is 1.86. Labat Africa's value of 0.33 is 82.2% below this industry median. Based on the distribution chart, Labat Africa ranks #38 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Labat Africa's PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Labat Africa ranks #38 out of 922 companies for PB Ratio. This places Labat Africa in the top 4% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.86. Labat Africa's value of 0.33 is 82.2% below this benchmark. Historically, Labat Africa's own PB Ratio has ranged from 0.33 to 145.00 over the past decade. While the company's 10-year median is 4.17 vs. the industry median of 1.86, Labat Africa has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.86, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labat Africa's current PB Ratio of 0.33 is 82.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Labat Africa and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labat Africa's current PB Ratio is 0.33, which is 92% below median its own 10-year median of 4.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.22, compared to a current price of R0.05 — trading 77.3% below its estimated fair value. The current PB Ratio is 0.33, which is 92% below median its 10-year median of 4.17 and 82.2% below the Drug Manufacturers industry median of 1.86. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current PB Ratio is 0.33 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:LAB has been successfully added to your 